Trinity Biotech
TRIB
92 hedge funds and large institutions have $212M invested in Trinity Biotech in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 7 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 27
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
0% more funds holding
Funds holding: 92 → 92 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
34% less capital invested
Capital invested by funds: $323M → $212M (-$111M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $186K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$10M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$6.74M |
| 3 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$3M |
| 4 |
Millennium Management
New York
|
+$2.94M |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$11.9M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$11.2M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$5.61M |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$3.41M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$2.38M |
TRIB Hedge Fund Activity: Q3 2015 in Review
92 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q3 2015, worth a combined $212M — down 34% from $323M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TRIB positions and 7 closed out — a net gain of 1 holder — while 39 added to existing stakes and 27 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $10M. The largest seller was William Blair & Company, cutting an estimated $11.9M.
- 92 institutional investors held Trinity Biotech (TRIB) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $212M of Trinity Biotech stock for Q3 2015, down 34% quarter-over-quarter.
- 8 funds opened new Trinity Biotech positions in Q3 2015 and 7 closed out, a net change of +1 holder.
- The largest Trinity Biotech buyer in Q3 2015 was Janus Henderson Investors US, an estimated $10M added.
- The largest Trinity Biotech seller in Q3 2015 was William Blair & Company, an estimated $11.9M sold.
Based on aggregated 13F filings for Q3 2015.